DA-3031 (PEG-G-CSF)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DA-3031 (PEG-G-CSF), covering 2014-10-01 to 2014-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia [Phase 2]